SCHOTT Pharma AG & Co KgaA
XETRA:1SXP
Income Statement
Earnings Waterfall
SCHOTT Pharma AG & Co KgaA
Revenue
|
1.1B
EUR
|
Cost of Revenue
|
-730.6m
EUR
|
Gross Profit
|
400.2m
EUR
|
Operating Expenses
|
-167.5m
EUR
|
Operating Income
|
232.7m
EUR
|
Other Expenses
|
-36.4m
EUR
|
Net Income
|
196.3m
EUR
|
Income Statement
SCHOTT Pharma AG & Co KgaA
Sep-2023 | Dec-2023 | ||
---|---|---|---|
Revenue | |||
Revenue |
899
N/A
|
1 131
+26%
|
|
Gross Profit | |||
Cost of Revenue |
(582)
|
(731)
|
|
Gross Profit |
316
N/A
|
400
+26%
|
|
Operating Income | |||
Operating Expenses |
(145)
|
(168)
|
|
Selling, General & Administrative |
(126)
|
(154)
|
|
Research & Development |
(27)
|
(33)
|
|
Other Operating Expenses |
7
|
19
|
|
Operating Income |
171
N/A
|
233
+36%
|
|
Pre-Tax Income | |||
Interest Income Expense |
17
|
11
|
|
Non-Reccuring Items |
7
|
4
|
|
Total Other Income |
(9)
|
(5)
|
|
Pre-Tax Income |
186
N/A
|
241
+30%
|
|
Net Income | |||
Tax Provision |
(34)
|
(45)
|
|
Income from Continuing Operations |
152
|
196
|
|
Income to Minority Interest |
(0)
|
(0)
|
|
Net Income (Common) |
152
N/A
|
196
+29%
|
|
EPS (Diluted) |
1.01
N/A
|
1.3
+29%
|